Krishna Mohan Puvvada, Regional President – Middle East, India and Africa
| Photo Credit: The Hindu
Danish biosolutions company Novonesis has announced an investment of ₹6,660 crore (€600 million) to expand its facility at Patalganga in Maharashtra and establish an advanced enzyme production facility.
The expansion is aimed at increasing the company’s production capacity to meet growing global demand for biosolutions. The new facility, which is expected to be fully operational by 2030, will manufacture enzymes for a range of industries, including biofuels, household care, and food and beverages.
“The expansion strengthens our ability to support customers around the world and enables us to continue creating long-term value for our shareholders,” said Ester Baiget, President and CEO of Novonesis.
According to the company, the Patalganga facility will form part of Novonesis’ global production network and bring the company closer to customers in key emerging markets, including the Middle East, Africa, India and wider South Asia.
“As demand for biosolutions continues to grow across industries and regions, expanding our global production capacity is a priority. The Patalganga expansion will strengthen our scale, operational resilience, efficiency, and supply flexibility,” said Anders Lund, Chief Operating Officer.
He added that the investment would also enable the company to serve customers in key growth markets more effectively and support its long-term growth targets.
Krishna Mohan Puvvada, Regional President for Middle East, India & Africa, said the investment would support Novonesis’ long-term growth ambitions while strengthening India’s position in the global bioeconomy.
“With the launch of the BioE3 policy by the Government of India, the country has taken transformative steps to unlock the true economic, social, and environmental potential of biosolutions for a net-zero carbon future,” Puvvada said.
Published – September 02, 2026 08:22 pm IST
